Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 2/2009

01.08.2009 | Case Report

Mucinous adenocarcinoma arising in ovarian mature cystic teratoma in pregnancy

verfasst von: Volkan Ulker, Ali Gedikbasi, Ceyhun Numanoglu, Yasemin Ozluk, Sezin Saygı, Ahmet Gulkilik, Yavuz Salihoglu

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

We report a case of mucinous adenocarcinoma arising from mature cystic teratoma (MCT) of the ovary ascertained incidentally during pregnancy. An ovarian adnexal mass was seen in a 38-year-old pregnant woman during cesarean section. Oophorectomy revealed a mucinous adenocarcinoma arising from MCT with additional capsule invasion. Following this, staging procedures were applied. The patient was staged as IC and adjuvant chemotherapy was applied. She has remained disease-free for over 24 months. To our knowledge, this is a case of mucinous adenocarcinoma arising from MCT and the third case of malignant transformation from MCT in pregnancy in English literature.
Literatur
1.
Zurück zum Zitat Curling ON, Potsides PN, Hudson CN (1979) Malignant change in benign cystic teratoma of ovary. Br J Obstet Gynaecol 86:399–402PubMed Curling ON, Potsides PN, Hudson CN (1979) Malignant change in benign cystic teratoma of ovary. Br J Obstet Gynaecol 86:399–402PubMed
3.
5.
7.
8.
Zurück zum Zitat Dos Santos L, Mok E, Iasonos A, Park K, Soslow RA, Aghajanian C, Alektiar K, Barakat RR, Abu-Rustum NR (2007) Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecol Oncol 105:321–324. doi:10.1016/j.ygyno.2006.12.008 PubMedCrossRef Dos Santos L, Mok E, Iasonos A, Park K, Soslow RA, Aghajanian C, Alektiar K, Barakat RR, Abu-Rustum NR (2007) Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecol Oncol 105:321–324. doi:10.​1016/​j.​ygyno.​2006.​12.​008 PubMedCrossRef
10.
Zurück zum Zitat Mekaru K, Kamiyama S, Masamoto H, Yagi C, Hirakawa M, Inamine M, Nagai Y, Sakumoto K, Aoki Y (2008) Squamous cell carcinoma arising in an ovarian mature cystic teratoma complicating pregnancy: a case report. Arch Gynecol Obstet 278:287–290. doi:10.1007/s00404-008-0573-z PubMedCrossRef Mekaru K, Kamiyama S, Masamoto H, Yagi C, Hirakawa M, Inamine M, Nagai Y, Sakumoto K, Aoki Y (2008) Squamous cell carcinoma arising in an ovarian mature cystic teratoma complicating pregnancy: a case report. Arch Gynecol Obstet 278:287–290. doi:10.​1007/​s00404-008-0573-z PubMedCrossRef
11.
12.
Zurück zum Zitat Kimura T, Inoue M, Miyake A, Tanizawa O, Oka Y, Amemiya K (1989) The use of serum TA-4 in monitoring patients with malignant transformation of ovarian mature cystic teratoma. Cancer 64:480–483. doi:10.1002/1097-0142(19890715)64:2<480::AID-CNCR2820640222>3.0.CO;2-7PubMedCrossRef Kimura T, Inoue M, Miyake A, Tanizawa O, Oka Y, Amemiya K (1989) The use of serum TA-4 in monitoring patients with malignant transformation of ovarian mature cystic teratoma. Cancer 64:480–483. doi:10.1002/1097-0142(19890715)64:2<480::AID-CNCR2820640222>3.0.CO;2-7PubMedCrossRef
13.
Zurück zum Zitat Mori Y, Nishii H, Takabe K, Shinozaki H, Matsumoto N, Suzuki K, Tanabe H, Watanabe A, Ochiai K, Tanaka T (2003) Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary. Gynecol Oncol 90:338–341. doi:10.1016/S0090-8258(03)00259-2 PubMedCrossRef Mori Y, Nishii H, Takabe K, Shinozaki H, Matsumoto N, Suzuki K, Tanabe H, Watanabe A, Ochiai K, Tanaka T (2003) Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary. Gynecol Oncol 90:338–341. doi:10.​1016/​S0090-8258(03)00259-2 PubMedCrossRef
15.
Zurück zum Zitat Blumenfeld W, Turi GK, Harrison G, Latuszynski D, Zhang C (1999) Utility of cytokeratin 7 and 20 subset analysis as an aid in the identification of primary site of origin of malignancy in cytologic specimens. Diagn Cytopathol 20:63–66. doi:10.1002/(SICI)1097-0339(199902)20:2<63::AID-DC3>3.0.CO;2-KPubMedCrossRef Blumenfeld W, Turi GK, Harrison G, Latuszynski D, Zhang C (1999) Utility of cytokeratin 7 and 20 subset analysis as an aid in the identification of primary site of origin of malignancy in cytologic specimens. Diagn Cytopathol 20:63–66. doi:10.1002/(SICI)1097-0339(199902)20:2<63::AID-DC3>3.0.CO;2-KPubMedCrossRef
17.
Zurück zum Zitat Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM (1995) Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 3:99–107 Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM (1995) Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem 3:99–107
18.
Zurück zum Zitat Lagendijk JH, Mullink H, Van Diest PJ, Meijer GA, Meijer CJ (1998) Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol 29:491–497. doi:10.1016/S0046-8177(98)90065-X PubMedCrossRef Lagendijk JH, Mullink H, Van Diest PJ, Meijer GA, Meijer CJ (1998) Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol 29:491–497. doi:10.​1016/​S0046-8177(98)90065-X PubMedCrossRef
19.
Zurück zum Zitat Vang R, Gown AM, Zhao C, Barry TS, Isacson C, Richardson MS, Ronnett BM (2007) Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol 31:854–869. doi:10.1097/PAS.0b013e31802efb45 PubMedCrossRef Vang R, Gown AM, Zhao C, Barry TS, Isacson C, Richardson MS, Ronnett BM (2007) Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary. Am J Surg Pathol 31:854–869. doi:10.​1097/​PAS.​0b013e31802efb45​ PubMedCrossRef
Metadaten
Titel
Mucinous adenocarcinoma arising in ovarian mature cystic teratoma in pregnancy
verfasst von
Volkan Ulker
Ali Gedikbasi
Ceyhun Numanoglu
Yasemin Ozluk
Sezin Saygı
Ahmet Gulkilik
Yavuz Salihoglu
Publikationsdatum
01.08.2009
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2009
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-008-0878-y

Weitere Artikel der Ausgabe 2/2009

Archives of Gynecology and Obstetrics 2/2009 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.